# ENAVATE SCIENCES GP, LLC: Form 13F holdings

An institutional investment manager in New York, NY. SEC CIK 1953107.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $345.4m
- Positions: 7 (7 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1953107/000195310726000012/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [SIONNA THERAPEUTICS INC (SION)](/companies/sion.md) | COM | $109.0m | 31.6% | 2,478,030 |  | Unchanged |
| [ZENAS BIOPHARMA INC (ZBIO)](/companies/zbio.md) | COM | $99.5m | 28.8% | 3,919,159 |  | Unchanged |
| [IMMUNOME INC (IMNM)](/companies/imnm.md) | COM | $76.6m | 22.2% | 3,613,799 |  | Unchanged |
| [BRIDGEBIO ONCOLOGY THERAPEUT (BBOT)](/companies/bbot.md) | COM NEW | $20.0m | 5.8% | 2,626,946 |  | Unchanged |
| [COMPASS THERAPEUTICS INC (CMPX)](/companies/cmpx.md) | COM | $17.1m | 4.9% | 7,788,150 |  | Unchanged |
| [UPSTREAM BIO INC (UPB)](/companies/upb.md) | COM | $17.0m | 4.9% | 2,459,703 |  | Unchanged |
| [CAMP4 THERAPEUTICS CORP (CAMP)](/companies/camp.md) | COM | $6.2m | 1.8% | 1,425,541 |  | Reduced −765,379 |

Source: SEC EDGAR, Form 13F-HR, accession 0001953107-26-000012. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.